{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:07:59Z","timestamp":1791515279260,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35GM116387"],"award-info":[{"award-number":["R35GM116387"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["I-1770"],"award-info":[{"award-number":["I-1770"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The cannabinoid receptor 1 (CB\n                    <jats:sub>1<\/jats:sub>\n                    R) regulates synaptic transmission in the central nervous system, but also has important roles in the peripheral organs controlling cellular metabolism. While earlier generations of brain penetrant CB\n                    <jats:sub>1<\/jats:sub>\n                    R antagonists advanced to the clinic for their effective treatment of obesity, such molecules were ultimately shown to exhibit negative effects on central reward pathways that thwarted their further therapeutic development. The peripherally restricted CB\n                    <jats:sub>1<\/jats:sub>\n                    R inverse agonists MRI-1867 and MRI-1891 represent a new generation of compounds that retain the metabolic benefits of CB\n                    <jats:sub>1<\/jats:sub>\n                    R inhibitors while sparing the negative psychiatric effects. To understand the mechanism of binding and inhibition of CB\n                    <jats:sub>1<\/jats:sub>\n                    R by peripherally restricted antagonists, we developed a nanobody\/fusion protein strategy for high-resolution cryo-EM structure determination of the GPCR inactive state, and used this method to determine structures of CB\n                    <jats:sub>1<\/jats:sub>\n                    R bound to either MRI-1867 or MRI-1891. These structures reveal how these compounds retain high affinity and specificity for CB\n                    <jats:sub>1<\/jats:sub>\n                    R\u2019s hydrophobic orthosteric site despite incorporating polar functionalities that lead to peripheral restriction. Further, the structure of the MRI-1891 complex along with accompanying molecular dynamics simulations shows how differential engagement with transmembrane helices and the proximal N-terminus can propagate through the receptor to contribute to biased inhibition of \u03b2-arrestin signaling.\n                  <\/jats:p>","DOI":"10.1038\/s41467-024-54206-0","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:18:16Z","timestamp":1734524296000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Structural mechanism of CB1R binding to peripheral and biased inverse agonists"],"prefix":"10.1038","volume":"15","author":[{"given":"Punita","family":"Kumari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szabolcs","family":"Dvor\u00e1csk\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3208-7043","authenticated-orcid":false,"given":"Michael D.","family":"Enos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrix","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-078X","authenticated-orcid":false,"given":"Sergio A.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1788-4976","authenticated-orcid":false,"given":"George","family":"Kunos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-7253","authenticated-orcid":false,"given":"Resat","family":"Cinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0116-4619","authenticated-orcid":false,"given":"Malliga R.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7174-4993","authenticated-orcid":false,"given":"Daniel M.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"key":"54206_CR1","first-page":"294","volume":"10","author":"DA Kendall","year":"2016","unstructured":"Kendall, D. A. & Yudowski, G. A. Cannabinoid receptors in the central nervous system: their signaling and roles in disease. Front Cell Neurosci. 10, 294 (2016).","journal-title":"Front Cell Neurosci."},{"key":"54206_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","volume":"64","author":"R Mechoulam","year":"2013","unstructured":"Mechoulam, R. & Parker, L. A. The endocannabinoid system and the brain. Annu Rev. Psychol. 64, 21\u201347 (2013).","journal-title":"Annu Rev. Psychol."},{"key":"54206_CR3","doi-asserted-by":"crossref","unstructured":"Gaoni, Y. & Mechoulam, R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc. (1964).","DOI":"10.1021\/ja01062a046"},{"key":"54206_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","volume":"46","author":"K Mackie","year":"2006","unstructured":"Mackie, K. Cannabinoid receptors as therapeutic targets. Annu. Rev. Pharmacol. Toxicol. 46, 101\u2013122 (2006).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"54206_CR5","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1111\/bph.15627","volume":"179","author":"K Ramesh","year":"2022","unstructured":"Ramesh, K. & Rosenbaum, D. M. Molecular basis for ligand modulation of the cannabinoid CB1 receptor. Br. J. Pharmacol. 179, 3487\u20133495 (2022).","journal-title":"Br. J. Pharmacol."},{"key":"54206_CR6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35071088","volume":"410","author":"VD Marzo","year":"2001","unstructured":"Marzo, V. D. et al. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822\u2013825 (2001).","journal-title":"Nature"},{"key":"54206_CR7","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","volume":"365","author":"LFV Gaal","year":"2005","unstructured":"Gaal, L. F. V. et al. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 365, 1389\u20131397 (2005).","journal-title":"Lancet"},{"key":"54206_CR8","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/S0140-6736(07)61721-8","volume":"370","author":"R Christensen","year":"2007","unstructured":"Christensen, R., Kristensen, P. K., Bartels, E. M., Bliddal, H. & Astrup, A. Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370, 1706\u20131713 (2007).","journal-title":"Lancet"},{"key":"54206_CR9","doi-asserted-by":"publisher","first-page":"107477","DOI":"10.1016\/j.pharmthera.2020.107477","volume":"208","author":"R Cinar","year":"2020","unstructured":"Cinar, R., Iyer, M. R. & Kunos, G. The therapeutic potential of second and third generation CB1R antagonists. Pharmacol. Ther. 208, 107477 (2020).","journal-title":"Pharmacol. Ther."},{"key":"54206_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2012.07.002","volume":"16","author":"J Tam","year":"2012","unstructured":"Tam, J. et al. Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab. 16, 167\u2013179 (2012).","journal-title":"Cell Metab."},{"key":"54206_CR11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1021\/acs.jmedchem.6b01504","volume":"60","author":"MR Iyer","year":"2017","unstructured":"Iyer, M. R. et al. Design, synthesis, and biological evaluation of novel, non-brain-penetrant, hybrid cannabinoid cb1r inverse agonist\/inducible nitric oxide synthase (iNOS) inhibitors for the treatment of liver fibrosis. J. Med. Chem. 60, 1126\u20131141 (2017).","journal-title":"J. Med. Chem."},{"key":"54206_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.87336","volume":"1","author":"R Cinar","year":"2016","unstructured":"Cinar, R. et al. Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis. JCI Insight 1, e87336 (2016).","journal-title":"JCI Insight"},{"key":"54206_CR13","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92281","volume":"2","author":"R Cinar","year":"2017","unstructured":"Cinar, R. et al. Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis. JCI Insight 2, e92281 (2017).","journal-title":"JCI Insight"},{"key":"54206_CR14","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1021\/acs.jmedchem.1c01836","volume":"65","author":"MR Iyer","year":"2022","unstructured":"Iyer, M. R. et al. Synthesis, biological evaluation, and molecular modeling studies of 3,4-diarylpyrazoline series of compounds as potent, nonbrain penetrant antagonists of cannabinoid-1 (CB1R) receptor with reduced lipophilicity. J. Med. Chem. 65, 2374\u20132387 (2022).","journal-title":"J. Med. Chem."},{"key":"54206_CR15","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1021\/acsptsci.1c00048","volume":"4","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Functional selectivity of a biased cannabinoid-1 receptor (CB1R) antagonist. ACS Pharmacol. Transl. Sci. 4, 1175\u20131187 (2021).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"54206_CR16","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/dom.15353","volume":"26","author":"GD Crater","year":"2024","unstructured":"Crater, G. D., Lalonde, K., Ravenelle, F., Harvey, M. & Despr\u00e9s, J. Effects of CB1R inverse agonist, INV\u2010202, in patients with features of metabolic syndrome. a randomized, placebo\u2010controlled, double\u2010blind phase 1b study. Diab., Obes. Metab. 26, 642\u2013649 (2024).","journal-title":"Diab., Obes. Metab."},{"key":"54206_CR17","doi-asserted-by":"publisher","unstructured":"Shao, Z. et al. High-resolution crystal structure of the human CB1 cannabinoid receptor. Nature https:\/\/doi.org\/10.1038\/nature20613 (2016).","DOI":"10.1038\/nature20613"},{"key":"54206_CR18","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","volume":"167","author":"T Hua","year":"2016","unstructured":"Hua, T. et al. Crystal structure of the human cannabinoid receptor CB1. Cell 167, 750\u2013762.e14 (2016).","journal-title":"Cell"},{"key":"54206_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cell.2018.11.040","volume":"176","author":"KK Kumar","year":"2019","unstructured":"Kumar, K. K. et al. Structure of a signaling cannabinoid receptor 1-G protein complex. Cell 176, 448\u2013458.e12 (2019).","journal-title":"Cell"},{"key":"54206_CR20","doi-asserted-by":"publisher","first-page":"5784","DOI":"10.1016\/j.cell.2023.11.017","volume":"186","author":"Y-Y Liao","year":"2023","unstructured":"Liao, Y.-Y. et al. Snapshot of the cannabinoid receptor 1-arrestin complex unravels the biased signaling mechanism. Cell 186, 5784\u20135797.e17 (2023).","journal-title":"Cell"},{"key":"54206_CR21","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/procel\/pwad055","volume":"15","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Cryo-EM structure of cannabinoid receptor CB1-\u03b2-arrestin complex. Protein Cell 15, 230\u2013234 (2023).","journal-title":"Protein Cell"},{"key":"54206_CR22","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.58464","volume":"9","author":"N Tsutsumi","year":"2020","unstructured":"Tsutsumi, N. et al. Structure of human Frizzled5 by fiducial-assisted cryo-EM supports a heterodimeric mechanism of canonical Wnt signaling. eLife 9, e58464 (2020).","journal-title":"eLife"},{"key":"54206_CR23","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/s41594-022-00859-8","volume":"29","author":"MJ Robertson","year":"2022","unstructured":"Robertson, M. J. et al. Structure determination of inactive-state GPCRs with a universal nanobody. Nat. Struct. Mol. Biol. 29, 1188\u20131195 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"54206_CR24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41589-019-0387-2","volume":"15","author":"Z Shao","year":"2019","unstructured":"Shao, Z. et al. Structure of an allosteric modulator bound to the CB1 cannabinoid receptor. Nat. Chem. Biol. 15, 1199\u20131205 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"54206_CR25","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41594-018-0028-6","volume":"25","author":"C McMahon","year":"2018","unstructured":"McMahon, C. et al. Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat. Struct. Mol. Biol. 25, 289\u2013296 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"54206_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"54206_CR27","doi-asserted-by":"publisher","first-page":"106236","DOI":"10.1016\/j.bioorg.2022.106236","volume":"130","author":"W-C Hsiao","year":"2023","unstructured":"Hsiao, W.-C. et al. Modulating the affinity and signaling bias of cannabinoid receptor 1 antagonists. Bioorg. Chem. 130, 106236 (2023).","journal-title":"Bioorg. Chem."},{"key":"54206_CR28","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/JME-14-0219","volume":"54","author":"P Gyombolai","year":"2015","unstructured":"Gyombolai, P., T\u00f3th, A. D., T\u00edm\u00e1r, D., Turu, G. & Hunyady, L. Mutations in the \u2018DRY\u2019 motif of the CB1 cannabinoid receptor result in biased receptor variants. J. Mol. Endocrinol. 54, 75\u201389 (2015).","journal-title":"J. Mol. Endocrinol."},{"key":"54206_CR29","doi-asserted-by":"publisher","first-page":"9841","DOI":"10.1021\/acs.jmedchem.8b00435","volume":"61","author":"L Tan","year":"2018","unstructured":"Tan, L., Yan, W., McCorvy, J. D. & Cheng, J. Biased ligands of G protein-coupled receptors (GPCRs): structure\u2013functional selectivity relationships (SFSRs) and therapeutic potential. J. Med. Chem. 61, 9841\u20139878 (2018).","journal-title":"J. Med. Chem."},{"key":"54206_CR30","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrd3024","volume":"9","author":"S Rajagopal","year":"2010","unstructured":"Rajagopal, S., Rajagopal, K. & Lefkowitz, R. J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9, 373\u2013386 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"54206_CR31","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nrd.2017.229","volume":"17","author":"JS Smith","year":"2018","unstructured":"Smith, J. S., Lefkowitz, R. J. & Rajagopal, S. Biased signalling: from simple switches to allosteric microprocessors. Nat. Rev. Drug Discov. 17, 243\u2013260 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"54206_CR32","doi-asserted-by":"crossref","unstructured":"Kenakin, T. Receptor Theory. Curr. Protoc. Pharmacol. 41, 1.2.1-1.2.28 (2008).","DOI":"10.1002\/0471141755.ph0102s41"},{"key":"54206_CR33","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fphar.2019.00605","volume":"10","author":"P Buchwald","year":"2019","unstructured":"Buchwald, P. A receptor model with binding affinity, activation efficacy, and signal amplification parameters for complex fractional response versus occupancy data. Front. Pharmacol. 10, 605 (2019).","journal-title":"Front. Pharmacol."},{"key":"54206_CR34","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1093\/ijnp\/pyy071","volume":"21","author":"KA Berg","year":"2018","unstructured":"Berg, K. A. & Clarke, W. P. Making sense of pharmacology: inverse agonism and functional selectivity. Int. J. Neuropsychopharmacol. 21, 962\u2013977 (2018).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"54206_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.cell.2013.01.008","volume":"152","author":"R Nygaard","year":"2013","unstructured":"Nygaard, R. et al. The dynamic process of \u03b2(2)-adrenergic receptor activation. Cell 152, 532\u2013542 (2013).","journal-title":"Cell"},{"key":"54206_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nature17668","volume":"533","author":"L Ye","year":"2016","unstructured":"Ye, L., Eps, N. V., Zimmer, M., Ernst, O. P. & Prosser, R. S. Activation of the A2A adenosine G-protein-coupled receptor by conformational selection. Nature 533, 265\u2013268 (2016).","journal-title":"Nature"},{"key":"54206_CR37","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.cell.2015.04.043","volume":"161","author":"A Manglik","year":"2015","unstructured":"Manglik, A. et al. Structural insights into the dynamic process of \u03b22-adrenergic receptor signaling. Cell 161, 1101\u20131111 (2015).","journal-title":"Cell"},{"key":"54206_CR38","doi-asserted-by":"publisher","first-page":"24433","DOI":"10.1074\/jbc.C100162200","volume":"276","author":"P Ghanouni","year":"2001","unstructured":"Ghanouni, P. Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor. J. Biol. Chem. 276, 24433\u201324436 (2001).","journal-title":"J. Biol. Chem."},{"key":"54206_CR39","doi-asserted-by":"publisher","first-page":"20284","DOI":"10.1073\/pnas.2009029117","volume":"117","author":"C McMahon","year":"2020","unstructured":"McMahon, C. et al. Synthetic nanobodies as angiotensin receptor blockers. Proc. Natl Acad. Sci. 117, 20284\u201320291 (2020).","journal-title":"Proc. Natl Acad. Sci."},{"key":"54206_CR40","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1074\/jbc.M507394200","volume":"281","author":"C Horcajada","year":"2006","unstructured":"Horcajada, C., Guinovart, J. J., Fita, I. & Ferrer, J. C. Crystal structure of an archaeal glycogen synthase: insights into oligomerization and substrate binding of eukaryotic glycogen synthases. J. Biol. Chem. 281, 2923\u20132931 (2006).","journal-title":"J. Biol. Chem."},{"key":"54206_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Meth 14, 331\u2013332 (2017).","journal-title":"Nat. Meth"},{"key":"54206_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsb.2015.11.003","volume":"193","author":"K Zhang","year":"2016","unstructured":"Zhang, K. Gctf: Real-time CTF determination and correction. J. Struct. Biol. 193, 1\u201312 (2016).","journal-title":"J. Struct. Biol."},{"key":"54206_CR43","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"54206_CR44","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D. Biol. Crystallogr 66, 213\u2013221 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"54206_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1107\/S0907444909042073","volume":"66","author":"VB Chen","year":"2010","unstructured":"Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D. Biol. Crystallogr 66, 12\u201321 (2010).","journal-title":"Acta Crystallogr D. Biol. Crystallogr"},{"key":"54206_CR46","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput Chem."},{"key":"54206_CR47","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"54206_CR48","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcc.21287","volume":"30","author":"BR Brooks","year":"2009","unstructured":"Brooks, B. R. et al. CHARMM: the biomolecular simulation program. J. Comput Chem. 30, 1545\u20131614 (2009).","journal-title":"J. Comput Chem."},{"key":"54206_CR49","doi-asserted-by":"publisher","DOI":"10.1063\/5.0014475","volume":"153","author":"JC Phillips","year":"2020","unstructured":"Phillips, J. C. et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. J. Chem. Phys. 153, 044130 (2020).","journal-title":"J. Chem. Phys."},{"key":"54206_CR50","doi-asserted-by":"publisher","first-page":"14668","DOI":"10.1021\/jp208184e","volume":"115","author":"SA Hassan","year":"2011","unstructured":"Hassan, S. A. & Steinbach, P. J. Water-exclusion and liquid-structure forces in implicit solvation. J. Phys. Chem. B 115, 14668\u201314682 (2011).","journal-title":"J. Phys. Chem. B"},{"key":"54206_CR51","doi-asserted-by":"publisher","first-page":"11985","DOI":"10.1021\/acs.jmedchem.3c00599","volume":"66","author":"S Dvora\u0301csko\u0301","year":"2023","unstructured":"Dvora\u0301csko\u0301, S. et al. Cannabinoformins: designing biguanide-embedded, orally available, peripherally selective cannabinoid-1 receptor antagonists for metabolic syndrome disorders. J. Med. Chem. 66, 11985\u201312004 (2023).","journal-title":"J. Med. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54206-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:05:49Z","timestamp":1734527149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-54206-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["54206"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-54206-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"2 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10694"}}